Solid Biosciences Inc. (NASDAQ:SLDB) Given Consensus Recommendation of “Buy” by Analysts
Shares of Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) have earned an average rating of “Buy” from the nine analysts that are covering the company, Marketbeat reports. Eight analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12-month price objective among […]
More Stories
Pines Wealth Management LLC Buys Shares of 2,725 The Goldman Sachs Group, Inc. (NYSE:GS)
Pines Wealth Management LLC purchased a new position in The Goldman Sachs Group, Inc. (NYSE:GS – Free Report) during the...
Sovereign Financial Group Inc. Acquires 1,549 Shares of JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI)
Sovereign Financial Group Inc. raised its holdings in JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI – Free Report) by 7.0% during...
Covea Finance Increases Stake in Becton, Dickinson and Company (NYSE:BDX)
Covea Finance increased its position in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) by 6.0% during the...
First Community Trust NA Acquires 185 Shares of Becton, Dickinson and Company (NYSE:BDX)
First Community Trust NA boosted its stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) by 2.6%...
Moseley Investment Management Inc. Boosts Stake in Vanguard Total World Stock ETF (NYSEARCA:VT)
Moseley Investment Management Inc. raised its position in shares of Vanguard Total World Stock ETF (NYSEARCA:VT – Free Report) by...
Plato Gold (CVE:PGC) Shares Down 20% – Here’s What Happened
Plato Gold Corp. (CVE:PGC – Get Free Report) shares dropped 20% on Wednesday . The company traded as low as...